Go to article
Posted by CoV Report on May 19, 2021 4:15 pmTags: Categories: US National Stories
House subcommittee members questioned why Emergent BioSoultions awarded bonuses to executives despite quality problems than hindered production of Johnson & Johnson’s COVID-19 vaccine.
(Image credit: Pool/Getty Images)
Your email address will not be published. Required fields are marked *
Comment *
Name *
Email *
Website
Save my name, email, and website in this browser for the next time I comment.
< The Coronavirus Report home
Everything you need to know to stay updated on the Coronavirus
Leave a Reply